TNF Pharmaceuticals, Inc. Quarterly Return On Equity in % from Q4 2014 to Q3 2024

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
TNF Pharmaceuticals, Inc. quarterly/annual Return On Equity history and growth rate from Q4 2014 to Q3 2024.
  • TNF Pharmaceuticals, Inc. Return On Equity for the quarter ending September 30, 2024 was -242 %, a 506% decline year-over-year.
  • TNF Pharmaceuticals, Inc. annual Return On Equity for 2023 was -30.9 %, a 65% increase from 2022.
  • TNF Pharmaceuticals, Inc. annual Return On Equity for 2022 was -88.4 %, a 46.6% increase from 2021.
  • TNF Pharmaceuticals, Inc. annual Return On Equity for 2021 was -165 %, a 166% decline from 2020.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q3 2024 -242 -202 -506% Jul 1, 2024 Sep 30, 2024
Q2 2024 -187 -94.3 -102% Apr 1, 2024 Jun 30, 2024
Q1 2024 -101 -20.3 -25.1% Jan 1, 2024 Mar 31, 2024
Q4 2023 -30.9 +57.5 +65% Oct 1, 2023 Dec 31, 2023
Q3 2023 -39.8 +35.8 +47.3% Jul 1, 2023 Sep 30, 2023
Q2 2023 -92.3 -15.1 -19.5% Apr 1, 2023 Jun 30, 2023
Q1 2023 -80.9 +42.5 +34.4% Jan 1, 2023 Mar 31, 2023
Q4 2022 -88.4 +77 +46.6% Oct 1, 2022 Dec 31, 2022
Q3 2022 -75.6 +209 +73.4% Jul 1, 2022 Sep 30, 2022
Q2 2022 -77.2 +786 +91.1% Apr 1, 2022 Jun 30, 2022
Q1 2022 -123 -346 -156% Jan 1, 2022 Mar 31, 2022
Q4 2021 -165 -415 -166% Oct 1, 2021 Dec 31, 2021
Q3 2021 -284 -501 -231% Jul 1, 2021 Sep 30, 2021
Q2 2021 -864 -1.25K -326% Apr 1, 2021 Jun 30, 2021
Q1 2021 222 +765 Jan 1, 2021 Mar 31, 2021
Q4 2020 250 +397 Oct 1, 2020 Dec 31, 2020
Q3 2020 217 +353 Jul 1, 2020 Sep 30, 2020
Q2 2020 382 +533 Apr 1, 2020 Jun 30, 2020
Q1 2020 -543 -407 -301% Jan 1, 2020 Mar 31, 2020
Q4 2019 -147 -26.2 -21.6% Oct 1, 2019 Dec 31, 2019
Q3 2019 -137 -18.8 -16% Jul 1, 2019 Sep 30, 2019
Q2 2019 -151 -42.5 -39% Apr 1, 2019 Jun 30, 2019
Q1 2019 -135 -21.6 -19% Jan 1, 2019 Mar 31, 2019
Q4 2018 -121 +12.2 +9.16% Oct 1, 2018 Dec 31, 2018
Q3 2018 -118 -18.5 -18.6% Jul 1, 2018 Sep 30, 2018
Q2 2018 -109 -45.2 -71% Apr 1, 2018 Jun 30, 2018
Q1 2018 -114 -42.7 -60.1% Jan 1, 2018 Mar 31, 2018
Q4 2017 -134 -56.2 -72.7% Oct 1, 2017 Dec 31, 2017
Q3 2017 -99.3 +14.7 +12.9% Jul 1, 2017 Sep 30, 2017
Q2 2017 -63.6 +67.8 +51.6% Apr 1, 2017 Jun 30, 2017
Q1 2017 -71 +42 +37.2% Jan 1, 2017 Mar 31, 2017
Q4 2016 -77.3 +9.84 +11.3% Oct 1, 2016 Dec 31, 2016
Q3 2016 -114 -61.8 -118% Jul 1, 2016 Sep 30, 2016
Q2 2016 -131 -93.1 -243% Apr 1, 2016 Jun 30, 2016
Q1 2016 -113 -87.8 -348% Jan 1, 2016 Mar 31, 2016
Q4 2015 -87.2 -67.5 -342% Oct 1, 2015 Dec 31, 2015
Q3 2015 -52.2 Jul 1, 2015 Sep 30, 2015
Q2 2015 -38.3 Apr 1, 2015 Jun 30, 2015
Q1 2015 -25.2 Jan 1, 2015 Mar 31, 2015
Q4 2014 -19.7 Oct 1, 2014 Dec 31, 2014
* An asterisk sign (*) next to the value indicates that the value is likely invalid.